(Reuters) -Tylenol maker Kenvue said on Monday that Johnson & Johnson will sell its remaining 9.5% stake in the company, ...
, opens new tab will sell its remaining 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its consumer health business. Based on Kenvue stock's last ...
Tylenol maker Kenvue has said that Johnson & Johnson will sell its remaining 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its consumer health business.
En un comunicado remitido a la Comisión de Bolsa y Valores de Estados Unidos (SEC), Kenvue ha informado de que se espera que Johnson & Johnson intercambie 182,32 millones de acciones ordinarias ...
La multinacional estadounidense Johnson & Johnson (J&J) se desprenderá de la participación del 9,5% que aún controlaba en Kenvue, su antiguo negocio de higiene personal y productos de consumo ...
(Reuters) – Tylenol maker Kenvue said on Monday that Johnson & Johnson will offload its entire 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its ...
(Reuters) – Tylenol maker Kenvue said on Monday that Johnson & Johnson will offload its entire 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its ...